Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Adamis Pharmaceuticals Q2 EPS $(0.06) Misses $(0.03) Estimate

Adamis Pharmaceuticals (NASDAQ:ADMP) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.03) by 100 percent. This is unchanged from the same period last year.
byMichael Horton
August 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Adamis Pharmaceuticals (NASDAQ:ADMP) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.03) by 100 percent. This is unchanged from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts